Stocks to Watch Today: Tata Power, MIDHANI, Aurobindo Pharma, Triveni Turbine and Others (November 12, 2026)

Benchmark indices are likely to track company-specific developments, quarterly earnings and corporate announcements as investors assess fresh triggers across sectors. 

Several stocks are expected to remain active following financial results, regulatory updates, strategic investments and significant institutional transactions. 

Tata Power Company Ltd 

Tata Power reported a 48.6% year-on-year increase in consolidated net profit to ₹1,366.1 crore for Q2FY27, compared with ₹919.4 crore. Revenue rose 26.3% to ₹19,635.9 crore from ₹15,544.9 crore. The results included an exceptional gain of ₹119.2 crore. 

The company's board also approved an investment of ₹11,871 crore for an 1,800 MW pumped storage project in Maharashtra. Sanjay Banga was appointed Additional Director and CEO Designate, effective November 11, 2026, and will take over as Managing Director and CEO from May 1, 2027, for five years. 

Mishra Dhatu Nigam Ltd (MIDHANI) 

Mishra Dhatu Nigam reported a 114.8% year-on-year increase in consolidated net profit to ₹27.8 crore in Q2FY27, compared with ₹13 crore in the corresponding quarter last year. 

Revenue increased 41.1% to ₹295.9 crore from ₹209.7 crore, reflecting improved financial performance during the quarter. 

Triveni Turbine Ltd 

Triveni Turbine reported a 41.6% decline in consolidated net profit to ₹53.3 crore in Q2FY27, against ₹91.2 crore in the year-ago period. 

Revenue declined 3% year-on-year to ₹491 crore from ₹506.2 crore, with both earnings and revenue registering a contraction during the quarter. 

DCX Systems Ltd 

DCX Systems reported a narrowing of its consolidated net loss to ₹0.25 crore in Q2FY27, compared with a loss of ₹9.04 crore in the corresponding quarter last year. 

However, revenue declined 27.3% to ₹140.2 crore from ₹192.9 crore, indicating weaker revenue performance despite the reduction in losses. 

Bajaj Finance Ltd 

Bajaj Finance launched its qualified institutions placement (QIP) on November 11, with the floor price fixed at ₹992.25 per equity share. 

The company may offer a discount of up to 5% on the floor price as part of the fundraising exercise. 

Aurobindo Pharma Ltd 

The US Food and Drug Administration (US FDA) classified the inspection outcome at Lannett Company LLC, a wholly owned step-down subsidiary of Aurobindo Pharma, as Official Action Indicated (OAI). 

The inspection was conducted at its Seymour facility in the US between August 17 and August 21, 2026. The regulator issued four observations, to which the company responded within the stipulated timeframe. 

ITC Ltd 

ITC has increased the price of its Gold Flake RSFT (69 mm) cigarette pack by ₹10 to ₹135 from the earlier price of ₹125, according to CNBC-TV18. 

The company had previously raised the price from ₹95 to ₹125 per pack in February 2026. 

Tata Investment Corporation Ltd 

Noel N Tata retired as Chairman and Director of Tata Investment Corporation, effective November 11, 2026. The company's board has appointed him Chairman Emeritus with effect from November 12, 2026. 

Read More: Cochin Shipyard Share Price in Focus; Bags ₹498.58 Crore INS Betwa Refit Contract! 

Aditya Infotech Ltd 

Dixon Technologies sold 14.04 lakh equity shares in Aditya Infotech, representing a 1.14% stake, for ₹581.65 crore through block deals. 

The shares were sold at ₹4,140 apiece, with Motilal Oswal Mutual Fund acquiring 8.42 lakh shares worth ₹348.99 crore and Kotak Mahindra Mutual Fund purchasing 5.61 lakh shares worth ₹232.66 crore. 

The transaction represents half of Dixon Technologies' 2.29% stake in Aditya Infotech as of September 2026. 

Conclusion 

Quarterly earnings, Tata Power's major investment announcement, Bajaj Finance's QIP, Aurobindo Pharma's regulatory update and block deals in Aditya Infotech are among the key developments likely to influence stock-specific activity during today's trading session. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks. Read all related documents carefully before investing.